STOCK TITAN

Planned sale of 713 SLGL shares by holder Itzik Yosef (NASDAQ: SLGL)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SLGL security holder Itzik Yosef filed a Form 144 notice to sell 713 ordinary shares. The planned sale is to be executed through Oppenheimer & Co. Inc. on or about 01/14/2026, with an aggregate market value of $44,876.22, and the shares are listed on Nasdaq. The filing states that 27,857,620 ordinary shares were outstanding.

The 713 shares were acquired on 08/02/2016 under an employee stock option plan from the issuer, with cash payment upon option exercise dated 01/15/2026. In the past three months, the same seller has reported sales of 398, 54 and 3 ordinary shares on 01/07/2026, 01/12/2026 and 01/13/2026, for gross proceeds of $19,974.27, $3,513.01 and $195.00, respectively.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SLGL Form 144 filing disclose?

The filing discloses that Itzik Yosef plans to sell 713 ordinary shares of SLGL on or about 01/14/2026 through Oppenheimer & Co. Inc., with an aggregate market value of $44,876.22.

How many SLGL shares is the insider currently planning to sell under this Form 144?

The notice covers a planned sale of 713 ordinary shares of SLGL, with an indicated aggregate market value of $44,876.22.

How and when were the SLGL shares being sold acquired?

The 713 ordinary shares were acquired on 08/02/2016 under an employee stock options plan from the issuer, with the purchase price to be paid in cash upon exercise on 01/15/2026.

What recent SLGL share sales has the filer reported over the past three months?

Over the past three months, Itzik Yosef reported sales of 398 shares on 01/07/2026 for $19,974.27, 54 shares on 01/12/2026 for $3,513.01, and 3 shares on 01/13/2026 for $195.00.

How many SLGL shares are outstanding according to this Form 144?

The Form 144 states that there are 27,857,620 ordinary shares of SLGL outstanding.

Which exchange is referenced for the SLGL ordinary shares in this Form 144?

The Form 144 identifies the securities exchange for the ordinary shares as Nasdaq.

Who is the broker named in the SLGL Form 144 sale plan?

The planned sale of 713 SLGL ordinary shares is to be executed through Oppenheimer & Co. Inc., 85 Broad St., New York, NY 10004.

Sol Gel Technolg

NASDAQ:SLGL

SLGL Rankings

SLGL Latest News

SLGL Latest SEC Filings

SLGL Stock Data

190.30M
835.67k
70%
20.62%
0.9%
Biotechnology
Healthcare
Link
Israel
Ness Ziona